At the end of September 2013, the EMCDDA and Europol examined the available information on a new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2- methoxybenzyl)phenethylamine, commonly known by the abbreviation ‘25I-NBOMe’, through
